Notice2026-21125
Meeting of the Advisory Council for the Elimination of Tuberculosis
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 16, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Council for the Elimination of Tuberculosis (ACET). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 lines are available). Time will be available for public comment (registration is required to provide oral comment; see the Oral Public Comment section below).
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 199 (Friday, October 16, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 199 (Friday, October 16, 2026)]
[Notices]
[Pages 65745-65746]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21125]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Council for the Elimination of
Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Council for the Elimination of
Tuberculosis (ACET). This meeting is open to the public, limited only
by the number of audio and web conference lines (1,000 lines are
available). Time will be available for public comment (registration is
required to provide oral comment; see the Oral Public Comment section
below).
DATES: The meeting will be held on December 2, 2026, from 12:00 p.m. to
4:30 p.m., EST, and on December 3, 2026, from 12:00 p.m. to 4 p.m.,
EST.
Written comments must be submitted by November 25, 2026.
Registration to make oral comments must also be submitted by November
25, 2026.
ADDRESSES: The public meeting will be held virtually through Microsoft
Teams. Advance registration is required to attend. Please register for
each day of this meeting.
For registration on December 2, 2026: <a href="https://events.gcc.teams.microsoft.com/event/ac21938b-f766-40e2-bf20-420cf442870f@9ce70869-60db-44fd-abe8-d2767077fc8f?source=copyLinkLegacyShareLinkDialog">https://events.gcc.teams.microsoft.com/event/ac21938b-f766-40e2-bf20-420cf442870f@9ce70869-60db-44fd-abe8-d2767077fc8f?source=copyLinkLegacyShareLinkDialog</a>. For registration on
December 3, 2026: <a href="https://events.gcc.teams.microsoft.com/event/126b55ca-74b3-4907-857d-2709a2bb82b7@9ce70869-60db-44fd-abe8-d2767077fc8f?source=copyLinkLegacyShareLinkDialog">https://events.gcc.teams.microsoft.com/event/126b55ca-74b3-4907-857d-2709a2bb82b7@9ce70869-60db-44fd-abe8-d2767077fc8f?source=copyLinkLegacyShareLinkDialog</a>. Registration for
virtual attendance will remain open through the meeting. Prior to the
meeting, each individual registrant will receive a registration
confirmation along with an access link to the virtual meeting location.
Written public comments and requests to make oral comments should be
sent to <a href="/cdn-cgi/l/email-protection#b1dfd2d9d9c2c5c1c1deddd8d2c8f1d2d5d29fd6dec7"><span class="__cf_email__" data-cfemail="610f020909121511110e0d080218210205024f060e17">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: ACET Committee Management, Office of
Policy, Planning, and Partnerships, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and
Prevention. Email: <a href="/cdn-cgi/l/email-protection#4b25282323383f3b3b24272228320b282f28652c243d"><span class="__cf_email__" data-cfemail="a6c8c5ceced5d2d6d6c9cacfc5dfe6c5c2c588c1c9d0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Council for the Elimination of Tuberculosis
is charged with providing advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, Centers
for Disease Control and Prevention (CDC). Specifically, the Council
makes recommendations regarding policies, strategies, objectives, and
priorities; addresses the development and application of new
technologies; provides guidance and review on CDC's Tuberculosis
Prevention Research portfolio and program priorities; and reviews the
extent to which progress has been made toward eliminating TB.
Matters to be Considered: The agenda will include discussions on:
(1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB
Prevention Update; (2) CDC's Division of Tuberculosis Elimination
Update; (3) Reported TB in the United States, 2025; (4) TB Diagnostics
Rapid Acceleration of Diagnostics Tech initiative; (5) TB Workforce
Update; (6) Tuberculosis Trials Consortium Update; (7) Study 38/CRUSH-
TB Clinical Trial; and (8) Post-Tuberculosis Lung Disease and
Mortality. Agenda items are subject to change as priorities dictate.
Public Participation
Written Public Comment: Members of the public are welcome to submit
written comments in advance of the meeting. Written comments must be
submitted by emailing <a href="/cdn-cgi/l/email-protection#107e737878636460607f7c797369507374733e777f66"><span class="__cf_email__" data-cfemail="731d101b1b000703031c1f1a100a331017105d141c05">[email protected]</span></a> with subject line ``ACET
December 2026 Written Public Comment Registration'' by November 25,
2026.
Oral Public Comment: Individuals who would like to make an oral
comment during the public comment period must register by emailing
<a href="/cdn-cgi/l/email-protection#b0ded3d8d8c3c4c0c0dfdcd9d3c9f0d3d4d39ed7dfc6"><span class="__cf_email__" data-cfemail="2f414c47475c5b5f5f4043464c566f4c4b4c01484059">[email protected]</span></a> with subject line ``ACET December 2026 Oral
Public Comment Registration'' by November 25, 2026. The public comment
period is on December 3, 2026, at 2 p.m., EST.
[[Page 65746]]
Comments are limited to no more than 5 minutes each. If the number of
persons requesting to speak is greater than can be reasonably
accommodated during the scheduled time, CDC will conduct a random draw
to determine the speakers for the scheduled public comment session. CDC
staff will notify individuals regarding their request to speak by email
by November 30, 2026 at 5 p.m. EST.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2026-21125 Filed 10-15-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 16, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.